Comprehensive, Team-based Care
Type 2 diabetes is a serious diagnosis on its own, affecting millions in the United States. What makes it even more dangerous and costly is that it is often accompanied by other serious or life-threatening conditions, including cardiovascular disease or diabetic kidney disease. The pancreas, heart, and kidneys are all at risk when these conditions converge, and heart disease is the leading cause of death in people with diabetes.
Instead of addressing conditions or risk factors separately, Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence has taken a novel approach to treating Type 2 diabetes, pre-diabetes, and related cardiovascular comorbidities together—providing team-based, comprehensive care specifically tailored to each patient and resulting in the formation of the Cardiometabolic Center Alliance.
Dr. Mikhail Kosiborod and team conduct an extensive patient history, the basis of our approach.